DPIIT recognised startup Government of India
Startup India
Raytwin Pharmaceutical Private Limited - pharma in Bhiwandi, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2025
₹23.28 Lakh
▼ 8% YoY
Net profit · FY 2025
₹35,350
Net margin 1.5%
EBITDA · FY 2025
₹2.46 Lakh
EBITDA margin 10.6%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹4 Lakh
Issued & subscribed
Open charges
₹10 Lakh
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
About Raytwin Pharmaceutical Private Limited
Data last updated:
Raytwin Pharmaceutical Private Limited is a private limited company based in Bhiwandi, Maharashtra, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 February 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2021PTC355230.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors Devesh Kumar Pathak (Managing Director) and Sarita Pathak.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No.2240/18 Flat 207 2nd Flr I – 2 Wing Riddhi Siddhi Complex, Bhiwandi, Maharashtra, India – 421302.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.28 Lakh, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹35,350 (net margin 1.5%) and EBITDA of ₹2.46 Lakh (EBITDA margin 10.6%). Revenue has grown at a compounded annual rate (CAGR) of 66% over three years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
Raytwin Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0069610). For more details, the company can be reached via its website raytwinpharma.com.
Company details
CIN U51909MH2021PTC355230
Registration Number 355230
Incorporation Date 15 February 2021
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0069610
Recognitions & Rankings of Raytwin Pharmaceutical
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0069610
Contact details
Raytwin Pharmaceutical Private Limited's registered office is in Bhiwandi, Maharashtra.
- Social Media
- Registered AddressH No.2240/18 Flat 207 2nd Flr I – 2 Wing Riddhi Siddhi Complex, Bhiwandi, Maharashtra, India – 421302
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Raytwin Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Raytwin Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Raytwin Pharmaceutical Private Limited, buy the company report.
Financials of Raytwin Pharmaceutical Private Limited
FY 2025 filings availableRaytwin Pharmaceutical Private Limited reported revenue of ₹23.28 Lakh (down 8% YoY) for FY 2025.
Revenue · FY 2025
₹23.28 Lakh ▼ 8%
Net profit · FY 2025
₹35,350 margin 1.5%
EBITDA · FY 2025
₹2.46 Lakh margin 10.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 8%
3 years · compounded
▲ 66%
EBITDA CAGR growth
1 year
▼ 41%
3 years · compounded
▲ 82%
Revenue fell 8% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 66%. EBITDA fell 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.46 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹35,350 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.6% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Raytwin Pharmaceutical Private Limited, buy the company report.
Board of directors of Raytwin Pharmaceutical Private Limited
Raytwin Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Devesh Kumar Pathak Also directs: Taswika Consumers Private Limited | Managing Director | 15 Feb 2021 | 5 Years 8 Months | Current |
| Sarita Pathak Also directs: Taswika Consumers Private Limited | Director | 25 Nov 2022 | 3 Years 11 Months | Current |
Peer comparison
Raytwin Pharmaceutical Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Paral Pharma Private Limited | ₹23.41 Lakh (FY 2025) | -98.0% | New Delhi, Delhi, India | |||
| Akshan Lifesciences Private Limited | ₹23.4 Lakh (FY 2025) | 9.0% | Dhanbad, Jharkhand, India | |||
| Derma Swift Health Care Private Limited | ₹23.39 Lakh (FY 2025) | 51.0% | New Delhi, Delhi, India | |||
| Raytwin Pharmaceutical Private Limitedthis company | ₹23.28 Lakh (FY 2025) | ₹35,350 | 1.5% | -8.0% | Bhiwandi, Maharashtra, India | |
| Caveat Pharma Private Limited | ₹23.16 Lakh (FY 2024) | 83.0% | Gurdaspur, Punjab, India | |||
| Joyce Healthcare Private Limited | ₹23.13 Lakh (FY 2017) | 62.0% | Thane, Maharashtra, India | |||
| Shard Lifesciences Private Limited | ₹23.06 Lakh (FY 2020) | -21.0% | Navi Mumbai, Maharashtra, India |
To see the full peer comparison of Raytwin Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
Open charges
₹10 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Mar 2024 | 100909490 | Others | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Raytwin Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Raytwin Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Raytwin Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Raytwin Pharmaceutical Private Limited has 4 board changes on record since 2021: 2 appointments and 2 cessations. The latest: Sarita Pathak ceased to be Additional Director on 12 Jan 2025.
AGM
Raytwin Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Raytwin Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Sarita Pathak ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 10.00 Lakh with Charge ID 100909490 was registered on 20 Mar 2024.
Ceased
Basant Kumar Pathak ceased to be Whole-Time Director.
Appointed
Sarita Pathak was appointed as Director.
Appointed
Devesh Kumar Pathak was appointed as Managing Director.
Incorporation
15 Feb 2021
Raytwin Pharmaceutical Private Limited was registered on 15 Feb 2021 with Roc Mumbai & aged 5 years 8 months as per MCA records.
Frequently asked questions
Raytwin Pharmaceutical is an active private limited company based in Bhiwandi, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 February 2021 (5+ years old) and is registered under CIN U51909MH2021PTC355230.
Raytwin Pharmaceutical has 2 current directors:
- Devesh Kumar Pathak - Managing Director
- Sarita Pathak - Director
The latest financial statements of Raytwin Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Raytwin Pharmaceutical is U51909MH2021PTC355230. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Raytwin Pharmaceutical was incorporated on 15 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Raytwin Pharmaceutical by revenue are Paral Pharma Private Limited, Akshan Lifesciences Private Limited, Derma Swift Health Care Private Limited, Caveat Pharma Private Limited, Joyce Healthcare Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Sarita Pathak ceased to be Additional Director on 12 Jan 2025. Basant Kumar Pathak ceased to be Whole-Time Director on 25 Nov 2022. Sarita Pathak was appointed as Director on 25 Nov 2022. Raytwin Pharmaceutical has 4 board changes on record in total.
Yes, Raytwin Pharmaceutical is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Raytwin Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0069610).
Raytwin Pharmaceutical can be reached through the website raytwinpharma.com. Its registered office is in Bhiwandi, Maharashtra, India.
The registered office of Raytwin Pharmaceutical is at H No.224018 Flat 207 2nd Flr I – 2 Wing Riddhi Siddhi Complex, Bhiwandi, Maharashtra, India – 421302.